"Le Centre hospitalier de Saint-Nazaire exerce ses activités dans un bâtiment commun ouvert en 2012 : la Cité sanitaire. Il dispose d'une offre de soins très large au niveau des disciplines de médecine, chirurgie, gynécologie-obstétrique, de soins de suite et de réadaptation, ainsi qu'un service d'accueil des urgences, de réanimation. Ces unités sont regroupées sur le site de la Cité Sanitaire. Des activités de soins en santé mentale, de prise en charge des personnes âgées, et de prévention et promotion de la santé sont proposés sur le site d'Heinlex situé à 800m."

During the past decade, CH Saint-Nazaire conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Saint-Nazaire" #1 sponsor was "Nantes University Hospital" with 24 trials, followed by "Centre Hospitalier Departemental Vendee" with 7 trials sponsored, "Rennes University Hospital" with 3 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored and "University Hospital, Brest" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Saint-Nazaire" #1 collaborator was "Ministry of Health, France" with 4 trials as a collaborator, "University Hospital, Tours" with 4 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Assistance Publique Hopitaux De Marseille" with 1 trials as a collaborator and "Bordeaux PharmacoEpi" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "CH Saint-Nazaire" are "Ventilator-associated Pneumonia" (3 trials), "ALK Gene Mutation" (1 trials), "ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2" (1 trials), "Acute Refractory Heart Failure Related to SARS-CoV 2" (1 trials) and "Advanced Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "CH Saint-Nazaire" in a lesser frequency.

Most popular intervention types in "CH Saint-Nazaire" are "Other" (17 trials), "Drug" (10 trials), "Device" (6 trials), "Genetic" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Endotracheal tubes allowing SSD" (3 trials), "Endotracheal tubes not allowing SSD" (3 trials), "Non interventional study" (3 trials), "no intervention" (3 trials) and "Administering diagnosis orientation questionnaires for the screening of possible sleep disorders" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Saint-Nazaire" are 47 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CH Saint-Nazaire". 1 are not yet recruiting, 12 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in CH Saint-Nazaire, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CH Saint-Nazaire, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 15 trials that are defined as “Not Applicable".